Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - will we see a profitable 1/4 when they announce??

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

paylslyone

Rank: Treasurer [?]

Points: 7504 [?]

Votes: 91 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

will we see a profitable 1/4 when they announce??

posted on Jan 04, 2012 06:06PM

PTSC cost (without write downs) has been running under 900,000 per 1/4.... we alos have an obligation to TPL of 86,000 a month until the markman...

TPL is obligated to pay us 1.1 million at 5 or 10% of each license's .. from court documents we know we have had some none announced license's.... we also had some PDGS income coming... so we have A SLIM CHANCE OF A PROFITABLE 1/4...